The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Abstract
The antitumor activity of disulfiram (DSF), a traditional US Food and Drug Administration-approved drug for the treatment of “alcohol-dependence”, is Cu 2+ -dependent, but the intrinsic anfractuous biodistribution of copper in the human body and copper toxicity induced by exogenous copper supply have severely hindered its in vivo application. Herein, we report an in situ Cu 2+ chelation-enhanced DSF-based cancer chemotherapy technique, using a tumor-specific “nontoxicity-to-toxicity” transition strategy based on hollow mesoporous silica nanoparticles as the functional carrier. Cu 2+ -doped, DSF-loaded hollow mesoporous silica nanoparticles were constructed for the rapid release of Cu 2+ ions induced by the mild acidic conditions of the tumor microenvironment. This resulted in the rapid biodegradation of the nanoparticles and accelerated DSF release once the particles were endocytosed into tumor cells. The resulting in situ chelation reaction between the coreleased Cu 2+ ions and DSF generated toxic CuET products and concurrently, Fenton-like reactions between the generated Cu + ions and the high levels of H 2 O 2 resulted in the production of reactive oxygen species (ROS) in the acidic tumor microenvironment. Both in vitro cellular assays and in vivo tumor-xenograft experiments demonstrated the efficient Cu-enhanced and tumor-specific chemotherapeutic efficacy of DSF, with cocontributions from highly toxic CuET complexes and ROS generated within tumors. This work provides a conceptual advancement of nanoparticle-enabled “nontoxicity-to-toxicity” transformation in tumors, to achieving high chemotherapeutic efficacy and biosafety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
Acute toxicological effects of copper nanoparticles in vivo
Chen, Z., Meng, H., Xing, G., Chen, C., Zhao, Y., Jia, G., Wang, T., Yuan, H., Ye, C., Zhao, F., et al. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.10.003 · Cited by 965
Intracellular Glutathione Detection Using MnO2-Nanosheet-Modified Upconversion Nanoparticles
Deng, R., Xie, X., Vendrell, M., Chang, Y.-T., & Liu, X. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2100774 · Cited by 936
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807
Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy
Lin, H., Chen, Y., & Shi, J. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00471k · Cited by 803
Self-citationOxygen Reduction by Homogeneous Molecular Catalysts and Electrocatalysts
Pegis, M. L., Wise, C. F., Martin, D. J., & Mayer, J. M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00542 · Cited by 675
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Chen, Y., Chen, H., Zeng, D., Tian, Y., Chen, F., Feng, J., & Shi, J. (2010) · ACS Nano · doi:10.1021/nn1015117 · Cited by 627
Self-citationKoppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005538 · Cited by 557
Self-citationA Cooperative Copper Metal–Organic Framework‐Hydrogel System Improves Wound Healing in Diabetes
Xiao, J., Chen, S., Yi, J., Zhang, H. F., & Ameer, G. A. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604872 · Cited by 428
Cellular Consequences of Copper Complexes Used To Catalyze Bioorthogonal Click Reactions
Kennedy, D. C., McKay, C. S., Legault, M. C. B., Danielson, D. C., Blake, J. A., Pegoraro, A. F., Stolow, A., Mester, Z., & Pezacki, J. P. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2083027 · Cited by 416
Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Liu, J., Liu, Y., Bu, W., Bu, J., Sun, Y., Du, J., & Shi, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5042989 · Cited by 332
Self-citationEffect of pH on Fenton and Fenton‐like oxidation
Jung, Y. S., Lim, W. T., Park, J., & Kim, Y. (2009) · Environmental Technology · doi:10.1080/09593330802468848 · Cited by 321
Guo, L., Panderi, I., Yan, D. D., Szulak, K., Li, Y., Chen, Y.-T., Ma, H., Niesen, D. B., Seeram, N., Ahmed, A., et al. (2013) · ACS Nano · doi:10.1021/nn403202w · Cited by 316
Self-citationYu, L., Chen, Y., Wu, M., Cai, X., Yao, H., Zhang, L., Chen, H., & Shi, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04299 · Cited by 305
Self-citationBai, J., Jia, X., Zhen, W., Cheng, W., & Jiang, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11114 · Cited by 272
Iljin, K., Ketola, K., Vainio, P., Halonen, P., Kohonen, P., Fey, V., Grafström, R. C., Perälä, M., & Kallioniemi, O. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1035 · Cited by 240
Wen, H.-Y., Dong, H.-Q., Xie, W.-J., Li, Y.-Y., Wang, K., Pauletti, G. M., & Shi, D.-L. (2011) · Chemical Communications · doi:10.1039/c0cc04983b · Cited by 217
Cvek, B., Milacic, V., Taraba, J., & Dou, Q. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007807 · Cited by 209
Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
Safi, R., Nelson, E. R., Chitneni, S. K., Franz, K. J., George, D. J., Zalutsky, M. R., & McDonnell, D. P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3527 · Cited by 201
Photoswitchable Antimetabolite for Targeted Photoactivated Chemotherapy
Matera, C., Gomila, A. M. J., Camarero, N., Libergoli, M., Soler, C., & Gorostiza, P. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08249 · Cited by 137
On the interaction of copper( ii ) with disulfiram
Lewis, D. J., Deshmukh, P., Tedstone, A. A., Tuna, F., & O’Brien, P. (2014) · Chemical Communications · doi:10.1039/c4cc04767b · Cited by 131
Liu, P., Wang, Z., Brown, S., Kannappan, V., Patricia, T. E., Jiang, W. G., Irache, J. M., Tang, J. Z., Britland, S. T., Armesilla, A. L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2166 · Cited by 124
Cvek, B. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.010 · Cited by 119
Zha, J., Chen, F., Dong, H., Shi, P., Yao, Y., Zhang, Y., Li, R., Wang, S., Li, P., Wang, W., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-163 · Cited by 111
Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
Sui, X., Xu, Y., Wang, X., Han, W., Pan, H., & Xiao, M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00577 · Cited by 96
Bateman, L. A., Zaro, B. W., Miller, S. M., & Pratt, M. R. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408322b · Cited by 88
The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
Tawari, P. E., Wang, Z., Najlah, M., Tsang, C. W., Kannappan, V., Liu, P., McConville, C., He, B., Armesilla, A. L., & Wang, W. (2015) · Toxicology Research · doi:10.1039/c5tx00210a · Cited by 86
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Conticello, C., Martinetti, D., Adamo, L., Buccheri, S., Giuffrida, R., Parrinello, N. L., Lombardo, L., Anastasi, G., Amato, G., Cavalli, M. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27482 · Cited by 86
Copper-Catalyzed Tyrosine Nitration
Qiao, L., Lu, Y., Liu, B., & Girault, H. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206980q · Cited by 77
The origin of an EPR signal observed in dithiocarbamate-loaded tissues
Suzuki, Y., Fujii, S., Teiji, T., Yoshimoto, T., Yoshimura, T., & Kamada, H. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00027-5 · Cited by 60
Wei, Y., Zhu, N., Lavoie, M., Wang, J., Qian, H., & Fu, Z. (2014) · BioMetals · doi:10.1007/s10534-014-9727-6 · Cited by 57
Signori, C., DuBrock, C., Richie, J. P., Prokopczyk, B., Demers, L. M., Hamilton, C., Hartman, T. J., Liao, J., El‐Bayoumy, K., & Manni, A. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.60 · Cited by 49
Potential biomarker for aspirin use in colorectal cancer therapy
Langley, R. E., & Rothwell, P. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.216 · Cited by 28
Cited by
Biomedicine Meets Fenton Chemistry
Tang, Z., Zhao, P., Wang, H., Liu, Y., & Bu, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00977 · Cited by 745
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 367
Wang, M., Chang, M., Chen, Q., Wang, D., Li, C., Hou, Z., Lin, J., Jin, D., & Xing, B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120093 · Cited by 322
Tian, H., Zhang, M., Jin, G., Jiang, Y., & Luan, Y. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.12.028 · Cited by 283
Biosafety of mesoporous silica nanoparticles; towards clinical translation
Lérida-Viso, A., Estepa-Fernández, A., García-Fernández, A., Martí-Centelles, V., & Martínez-Máñez, R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115049 · Cited by 279
Metadata
- Authors
- Wu, W., Yu, L., Jiang, Q., Huo, M., Lin, H., Wang, L., Chen, Y., & Shi, J.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-06-28
- Volume
- 141
- Issue
- 29
- Pages
- 11531-11539
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2954483872
- Cited by
- 359
- References
- 37
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.